Palpitations

Introduction

Palpitations refer to the subjective sensation of an abnormal or irregular heartbeat. Individuals experiencing palpitations may describe their heart as pounding, racing, fluttering, skipping beats, or feeling like it is "flip-flopping" in their chest. While often benign, these sensations can be alarming and lead to significant anxiety.

Biological Basis

The biological basis of palpitations lies in the heart's rhythm and force of contraction. They can arise from various changes in cardiac activity, including alterations in heart rate (tachycardia or bradycardia), rhythm disturbances (arrhythmias like premature atrial or ventricular contractions, atrial fibrillation), or an increase in the force of contraction. The autonomic nervous system plays a crucial role in regulating heart function, and imbalances can contribute to palpitations. Additionally, non-cardiac factors such as anxiety, stress, caffeine intake, certain medications, thyroid disorders, and anemia can also trigger these sensations.

Genetic Basis

Genetic factors can predispose individuals to conditions that manifest as palpitations. This includes inherited cardiac conditions such as channelopathies (e.g., Long QT syndrome, Brugada syndrome), which affect the electrical activity of the heart and can lead to arrhythmias. Similarly, genetic predispositions to cardiomyopathies, which are diseases of the heart muscle, can also result in structural or functional abnormalities that cause palpitations. Furthermore, genetic influences on neurochemical pathways may contribute to anxiety disorders, which are a common non-cardiac cause of palpitations.

Clinical Relevance

Palpitations are a frequent complaint in clinical practice, prompting many individuals to seek medical attention. Their clinical relevance spans a wide spectrum, from being a harmless and transient symptom to indicating a potentially life-threatening underlying cardiac condition. A thorough medical evaluation, including a detailed history, physical examination, and often diagnostic tests like electrocardiograms (ECGs) or Holter monitoring, is essential to determine the cause and guide appropriate management.

The social importance of palpitations extends beyond their physiological manifestations. For many, the experience can be distressing, leading to anxiety, panic attacks, and fear of serious illness. This can significantly impact an individual's quality of life, affecting their ability to perform daily activities, work, and engage in social interactions. The diagnostic process and potential treatments also carry an economic burden on healthcare systems and individuals.

Phenotypic Definition and Cohort Representativeness

The study's reliance on electronic medical records (EMRs) and PheCode classifications, while advantageous for longitudinal data, introduces inherent limitations in phenotype definition. The criterion of requiring three or more diagnostic instances for case classification, while reducing false positives, means that initial or less frequently documented diagnoses might be missed, potentially impacting the sensitivity and precision of defining conditions for genetic association analyses. ^[1] Furthermore, the hospital-centric design of the HiGenome cohort presents a challenge in its representativeness, as it largely excludes "subhealthy individuals," meaning most participants have at least one documented diagnosis. ^[1] This absence of a truly healthy control group can limit the ability to fully elucidate disease etiology in the general population and may introduce biases when generalizing findings to broader, unselected populations. ^[1]

Ancestry-Specific Genetic Architecture and Generalizability

A significant limitation stems from the study's focus on the Taiwanese Han population, primarily representing Eastern Asian (EAS) ancestry. ^[1] While this addresses the underrepresentation of non-European populations in genetic research, it inherently limits the direct generalizability of the findings to other ethnic groups. ^[1] The research itself demonstrates that genetic risk factors are often ancestry-specific, with observed discrepancies in effect sizes for certain variants between the Taiwanese Han population and European cohorts. ^[1] Consequently, polygenic risk score (PRS) models and genetic associations identified within this EAS cohort may exhibit suboptimal predictive power or differing effects when applied to individuals of diverse ancestral backgrounds, highlighting the critical need for ancestry-tailored genetic models. ^[1]

Unaccounted Environmental and Lifestyle Confounders

The complex etiology of most diseases, including those investigated, is understood to involve an intricate interplay between genetic predispositions and environmental factors. ^[1] While this study identifies genetic associations and develops PRS models, it acknowledges that a comprehensive understanding is limited by the current exclusion of various non-genetic factors. ^[1] Key environmental and lifestyle confounders, such as exercise habits, dietary patterns, alcohol consumption, and smoking status, were not incorporated into the genetic models. ^[1] The omission of these significant variables means that the genetic findings may not fully capture the complete picture of disease risk, and their integration in future research could substantially enhance the accuracy and applicability of predictive models. ^[1]

Variants

Genetic variations, such as single nucleotide polymorphisms (SNPs), can influence the expression and function of genes, potentially contributing to a range of health conditions, including cardiovascular symptoms like palpitations. The variant rs117999315 is associated with the genes _ZFAND2AP1_ and _NECTIN3-AS1_, both of which are involved in fundamental cellular processes that, when disrupted, can impact cardiac function. Studies on genetic architecture often identify such variants and their associations with various traits, including those affecting the circulatory system, within specific populations. ^[1] Palpitations, often described as a sensation of a racing or irregular heartbeat, can stem from underlying electrical or structural abnormalities in the heart, making the investigation of associated genetic factors crucial.

The gene _ZFAND2AP1_ is classified as a pseudogene, meaning it is a DNA sequence that resembles a functional gene but typically lacks protein-coding ability due to mutations. However, pseudogenes are increasingly recognized for their potential regulatory roles, such as acting as decoys for microRNAs or influencing the expression of neighboring functional genes. A variant like rs117999315 located within or near _ZFAND2AP1_ could affect its transcription, stability, or its interaction with other regulatory molecules, thereby indirectly modulating gene networks critical for cardiac rhythm and excitability. Such alterations could contribute to the electrical instability that manifests as palpitations. Genome-wide association studies (GWAS) employ stringent statistical thresholds to identify significant associations between such variants and health outcomes. ^[1]

Similarly, _NECTIN3-AS1_ is a long non-coding RNA (lncRNA) that plays a role in gene regulation, often by influencing the expression of nearby protein-coding genes like _NECTIN3_. _NECTIN3_ (also known as PVRL3) is involved in cell-cell adhesion, a process vital for maintaining the structural integrity and synchronized electrical activity of cardiac muscle cells. If rs117999315 impacts the expression or function of _NECTIN3-AS1_, it could lead to compromised cell adhesion or altered signaling pathways within the heart. These disruptions can impair the heart's ability to contract uniformly, potentially causing arrhythmias and the subjective experience of palpitations. Comprehensive analyses, often using PheCode classifications, categorize and study such genetic associations across a wide spectrum of human phenotypes. ^[1]

Key Variants

RS ID	Gene	Related Traits
rs117999315	ZFAND2AP1 - NECTIN3-AS1	palpitations

Operationalizing Disease Traits within Research Frameworks

Within the context of large-scale genetic studies, the precise definition and operationalization of disease traits are critical for establishing robust case-control cohorts. For any given trait, including a symptom complex like palpitations, diagnostic criteria are typically established through standardized systems. In the described research, medical diagnoses were rigorously defined using PheCode criteria, which required at least three distinct diagnostic instances to classify an individual as a "case" for a particular disease. This multi-instance criterion serves as an operational definition to enhance diagnostic accuracy and reliability, distinguishing true disease states from transient symptoms or single diagnostic errors. . Polygenic risk scores (PRSs) serve as a comprehensive approach to quantify an individual's inherited susceptibility by summarizing the cumulative effects of numerous genetic variants. ^[1] The genetic architecture contributing to such traits can be population-specific, as evidenced by variants like rs6546932 in the SELENOI gene, which exhibited a distinct effect size in the Taiwanese Han population compared to other ancestries. ^[1] Research shows significant genetic associations for circulatory system traits, often involving multiple genes, highlighting a substantial genetic component in their etiology. ^[1]

Environmental and Lifestyle Factors

Palpitations, as a manifestation of circulatory system health, are significantly shaped by a combination of genetic predispositions and environmental exposures. While specific environmental triggers for palpitations are not exhaustively detailed, broader research indicates that lifestyle elements such as diet, exercise habits, alcohol consumption, and smoking are critical modifiable factors influencing overall disease risk. ^[1] Incorporating these environmental variables into predictive models, alongside genetic data, substantially improves the accuracy of assessing an individual's susceptibility to various conditions, including those affecting the cardiovascular system. ^[1] The geographic and demographic context, such as the Taiwanese Han population studied, also provides a specific setting for understanding disease prevalence and the interaction of environmental factors within that population. ^[1]

Gene-Environment Interactions

The etiology of complex traits like palpitations involves intricate gene-environment interactions, where an individual's genetic blueprint responds dynamically to external stimuli. Polygenic risk scores (PRSs) are valuable tools that not only quantify the cumulative impact of genetic variants but also integrate various environmental factors into comprehensive disease susceptibility models. ^[1] This integration allows for a more nuanced understanding of how genetic predispositions are modulated by lifestyle choices, such as dietary patterns, physical activity levels, and exposure to substances like alcohol or tobacco. ^[1] By considering both inherited risk and environmental triggers, a more accurate and holistic picture of an individual's risk for palpitations and related circulatory conditions can be established. ^[1]

Age stands out as a prominent non-genetic factor that profoundly influences the prevalence and risk of palpitations and other circulatory system diseases. The accuracy of predictive models for various conditions consistently improves with the inclusion of age, reflecting its strong impact on disease progression. ^[1] Furthermore, several clinical features function as significant comorbidities or contributing factors, acting synergistically with genetic and environmental influences. These include sex, body mass index (BMI), blood pressure, and specific biomarkers like glycated hemoglobin levels, all of which are essential for a complete assessment of an individual's overall health and risk profile. ^[1]

Genetic Architecture of Complex Traits

The underlying biology of traits, such as those affecting the circulatory system, often involves complex genetic architectures rather than simple inheritance patterns. ^[1] Research indicates that the development of many traits is not determined by a single gene, but rather by the intricate interplay of multiple genetic variants and various environmental influences. ^[1] Genome-wide association studies (GWASs) are instrumental in exploring these associations, identifying numerous genetic variants linked to specific traits. Traits classified under the circulatory system, which would include conditions that manifest as palpitations, have been identified as having significant genetic associations, with many having multiple associated gene loci. ^[1]

Polygenic Risk and Susceptibility

Polygenic risk scores (PRSs) offer a comprehensive approach to quantify an individual's genetic predisposition to complex traits by summarizing the cumulative effects of numerous genetic variants across the genome. ^[1] These scores play a vital role in assessing disease susceptibility and can be further refined by incorporating clinical features and environmental factors, thereby enhancing their predictive accuracy. ^[1] The number of genetic variants contributing to a PRS model can vary considerably, demonstrating how a broad spectrum of genetic differences collectively influences the likelihood and manifestation of various health conditions. ^[1] Such models help to understand how genetic predispositions contribute to the development of traits like those impacting the circulatory system.

Population-Specific Genetic Influences

An individual's unique genetic risk factors for traits are significantly shaped by their ancestral background. ^[1] This highlights that genetic architectures and their associations with traits can differ markedly across diverse populations, necessitating the development of ancestry-specific genetic models for accurate risk assessment. ^[1] For example, a specific variant, rs6546932 in the SELENOI gene, has shown different effect sizes in the Taiwanese Han population compared to other cohorts, underscoring the critical impact of population-specific genetic backgrounds on disease associations. ^[1] These differences emphasize the importance of tailoring genetic research and clinical applications to the specific genetic makeup of the population being studied.

Large-scale Cohort Studies and Longitudinal Insights

Large-scale cohort studies, such as the HiGenome cohort in the Taiwanese Han population, are fundamental for understanding the population-level characteristics and temporal patterns of various health conditions. This extensive project, initiated in 2018, aims to explore genetic predispositions to common diseases and establish refined prediction and prevention systems. ^[1] Comprising 323,397 participants after exclusions for ancestry and relatedness, and with recruitment ongoing, the HiGenome cohort integrates deeply curated electronic medical records (EMRs) from China Medical University Hospital (CMUH) spanning from 2003 to 2021. ^[1] Such longitudinal data, with a significant proportion of participants followed for over 15 years, is invaluable for tracing the natural history, incidence trends, and long-term outcomes of symptoms like palpitations, providing a robust foundation for epidemiological analysis.

The HiGenome cohort’s data includes detailed patient demographics, laboratory results, medical procedures, and diagnostic codes, systematically converted into 1085 PheCodes for consistent phenotype classification. ^[1] This rigorous approach, where diagnoses are established based on at least three distinct instances, enhances data accuracy compared to studies relying on self-reported information, which can be prone to recall bias. ^[1] The extensive follow-up periods enable researchers to observe the temporal progression of conditions and the emergence of new diagnoses, offering crucial insights into the evolving prevalence and incidence rates of diverse health issues across the population.

Epidemiological Associations and Demographic Patterns

Epidemiological studies leveraging large cohorts like HiGenome reveal critical associations between demographic factors and disease patterns, which are applicable to understanding conditions such as palpitations. Analysis of the HiGenome cohort showed participant ages ranging from 0 to 111 years, with a male-to-female ratio of 45.3:54.7, reflecting a broad representation of the population. ^[1] While specific findings for palpitations are not detailed, the study observed that the incidence of most diseases increased with age, and many traits were associated with a higher median age in the disease group compared to controls. ^[1] Such demographic analyses are essential for identifying high-risk groups and understanding how age and sex influence the prevalence and presentation of symptoms like palpitations within the population.

The analysis of diagnostic instances within the HiGenome cohort demonstrated a significant increase in recorded diagnoses from 800,000 in 2003 to approximately 7 million by 2021, with an annual average of 3 million. ^[1] Many of these diagnoses were related to the circulatory system, neoplasms, and endocrine/metabolic systems, highlighting common health concerns in the Taiwanese Han population. ^[1] By examining these large-scale patterns, researchers can infer potential epidemiological associations and prevalence trends for conditions often linked to the circulatory system, like palpitations, and explore their correlations with demographic factors and disease characteristics across different age and gender groups.

Cross-Population Genetic Diversity

Cross-population comparisons are vital for understanding how genetic architectures and disease associations, relevant to conditions like palpitations, vary across different ancestral and ethnic groups. Studies like the HiGenome cohort emphasize the necessity of considering ancestry-specific genetic backgrounds in polygenic risk score (PRS) models, as genetic risk factors are predominantly influenced by an individual's ancestry. ^[1] The HiGenome cohort, which primarily consists of individuals from the East Asian (EAS) population, including Southern Han Chinese, Han Chinese from Beijing, and Kinh individuals from Ho Chi Minh, Vietnam, provides a unique and extensive dataset for this purpose. ^[1] This focus on a specific ancestry allows for the identification of population-specific genetic variants that may have different effect sizes or even different associations compared to those found in predominantly European cohorts.

An illustrative example from the research highlights a significant discrepancy for rs6546932 in the SELENOI gene, which exhibited an odds ratio (OR) of 1.58 in the Taiwanese Han population but a much smaller effect size (corresponding to an OR of 1.21) in the UK Biobank. ^[1] This finding underscores the potential for suboptimal outcomes when PRS models primarily designed for European cohorts are applied to other ethnic groups and emphasizes the importance of tailoring genetic risk assessments to different ancestries. ^[1] Such ancestry-specific research is crucial for accurately assessing genetic predispositions to various health conditions, including those that might manifest as palpitations, ensuring that risk prediction models are equitable and effective across diverse global populations.

Methodological Approaches and Generalizability

The methodological rigor employed in population studies, such as the HiGenome cohort, is central to their reliability and generalizability. The study utilizes a case-control design based on PheCode classifications, where cases are defined by three or more diagnostic instances, and controls are individuals without PheCode-defined diseases. ^[1] Genetic data were obtained using a custom Affymetrix Axiom TPMv1 SNP array, which was then enhanced through imputation to nearly 14 million reference points using whole-genome sequencing data from the Taiwanese population, ensuring comprehensive genetic coverage. ^[1] Genome-wide association studies (GWASs) and phenome-wide association studies (PheWASs) were conducted using logistic regression models, adjusted for confounders like age, sex, and principal components, to identify significant genetic associations with 1085 phenotypes. ^[1]

The HiGenome cohort's unique strength lies in its integration of detailed physician-documented EMRs, which minimizes the recall bias often associated with self-reported data in other large biobanks like the UK Biobank and MVP. ^[1] This approach enhances the accuracy of disease classification, particularly for chronic and progressive conditions. While the study provides a robust dataset for the Taiwanese Han population, considerations for generalizability to other ethnic groups are acknowledged, emphasizing the need for ancestry adjustments in future PRS models. ^[1] The large sample size and extensive longitudinal follow-up contribute significantly to the representativeness of the findings within the East Asian population, providing a valuable resource for understanding the complex interplay of genetic and clinical factors in various diseases.

Frequently Asked Questions About Palpitations

These questions address the most important and specific aspects of palpitations based on current genetic research.

1. My mom has a "racing heart." Will I get palpitations too?

Yes, there's a higher chance. Genetic factors can predispose you to conditions like channelopathies or cardiomyopathies, which often run in families and cause palpitations. If these conditions are in your family, you might inherit that underlying risk.

2. Why does coffee make my heart race, but not my friend's?

It could be due to your genetic makeup. While caffeine is a known trigger, your unique genetic profile might make your heart's electrical system more sensitive to stimulants, leading to palpitations when others are unaffected.

3. Does my anxiety cause my heart to flutter, or is there a genetic link?

It can be both. Genetic influences on neurochemical pathways can predispose you to anxiety disorders, which then trigger palpitations. So, genetics might make you more prone to anxiety-induced palpitations.

4. I'm Asian; does my background change my risk for heart flutters?

Yes, it can. Genetic risk factors for heart conditions and palpitations can vary significantly between different ancestral groups. Research, like studies on the Taiwanese Han population, shows that certain genetic associations are ancestry-specific.

5. How can I tell if my palpitations are serious or just stress?

It's hard to tell on your own. While stress is a common trigger, palpitations can also signal serious inherited conditions like Long QT syndrome or cardiomyopathies. A thorough medical evaluation is essential to differentiate between benign and potentially life-threatening causes.

6. Can I prevent palpitations even if they run in my family?

You can often manage them. While you can't change your genes, understanding your genetic predisposition can help your doctor tailor lifestyle advice and treatments. Avoiding triggers like excessive caffeine or stress, and managing underlying conditions, can reduce occurrences.

7. Do certain medicines make my heart skip beats because of my genes?

Potentially, yes. Some medications can trigger palpitations, and your genetic profile might make you more susceptible to these side effects by influencing how your body processes drugs or affecting your heart's electrical stability.

8. My heart feels like it "flip-flops." Is that a specific genetic issue?

That "flip-flop" feeling often describes premature heartbeats, which can have genetic roots. Conditions like channelopathies, which affect the heart's electrical activity, can cause these sensations, making some individuals more prone to such arrhythmias.

9. Is a DNA test useful to understand my heart palpitations?

It can be, especially if there's a family history of heart conditions. Genetic testing can identify specific inherited cardiac conditions like channelopathies or cardiomyopathies, providing valuable insights for diagnosis, risk assessment, and treatment planning.

10. Why do I get palpitations when I'm stressed, but others don't?

Your genetic makeup might play a role in how your body responds to stress. Genetic influences on your autonomic nervous system or neurochemical pathways could make your heart more reactive to stress, leading to palpitations more easily than in others.

This FAQ was automatically generated based on current genetic research and may be updated as new information becomes available.

Disclaimer: This information is for educational purposes only and should not be used as a substitute for professional medical advice. Always consult with a healthcare provider for personalized medical guidance.

References

[1] Liu, T. Y. et al. "Diversity and longitudinal records: Genetic architecture of disease associations and polygenic risk in the Taiwanese Han population." Science Advances, vol. 11, 4 June 2025.